RFS | OS | |||
Variable | Median (mo) | P | Median (mo) | P |
Tumor size | 0.0001 | 0.0008 | ||
≤2 cm | 42.0 | — | ||
>2 cm | 9.9 | 21.4 | ||
pT stage | 0.0002 | 0.004 | ||
Tx, T1 | 46.9 | — | ||
T2–T3 | 11.0 | 23.0 | ||
Lymph node metastasis | 0.03 | 0.07 | ||
No | 17.5 | 37.2 | ||
Yes | 10.3 | 22.0 | ||
Serum CA19-9 level | 0.2 | 0.1 | ||
≤180 U/mL | 12.2 | 34.4 | ||
>180 U/mL | 12.7 | 21.4 | ||
SUVmax | 0.03 | 0.03 | ||
≤4.7 | 12.9 | 34.4 | ||
>4.7 | 9.9 | 20.6 | ||
MTV | 0.0004 | 0.001 | ||
≤3.0 cm3 | 42.0 | — | ||
>3.0 cm3 | 10.3 | 21.4 | ||
TLG | 0.001 | 0.001 | ||
≤10.0 g | 25.6 | — | ||
>10.0 g | 9.9 | 21.4 | ||
Glucose-corrected SUVmax | 0.002 | 0.003 | ||
≤3.7 | 42.0 | — | ||
>3.7 | 11.1 | 22.0 | ||
Glucose-corrected TLG | 0.006 | 0.05 | ||
≤15.0 g | 47.7 | 37.2 | ||
>15.0 g | 20.9 | 21.4 |